IOVA ▼ -2.6% - Iovance Biotherapeutics, Inc.
$IOVA - Iovance Presents New Data at ESMO 2026 Demonstrating Deep, Durable Responses with Lifileucel TIL Cell Therapy Plus Pembrolizumab in Frontline Advanced Melanoma
23-OCT-2026 10:15 AM ET
Share this post
More filings for $IOVA
IOVA ▼ -0.7% - Iovance Biotherapeutics, Inc.Oct 19, 2026IOVA ▲ +0.2% - Iovance Biotherapeutics, Inc.Oct 1, 2026IOVA ▲ +0.3% - Iovance Biotherapeutics, Inc.Sep 30, 2026IOVA ▲ +3.7% - Iovance Biotherapeutics, Inc.Sep 29, 2026IOVA ▲ +2.3% - Iovance Biotherapeutics, Inc.Sep 18, 2026IOVA ▲ +1.1% - Iovance Biotherapeutics, Inc.Sep 4, 2026
View full $IOVA filing history →💬 Comments
Loading comments…
Leave a comment